Topics
July/August 2018
Share:
By Robin D. Ross, MD, MPH, CPH
Caroline R. Baumal, MD; and Audina M. Berrocal, MD
Ariel Tyring, MD; Steven S. Saraf, MD; and Lisa C. Olmos de Koo, MD
Timothy G. Murray, MD, MBA, FACS; Victor Villegas, MD; Aaron Gold, OD; Audina M. Berrocal, MD; and Ziad Khatib, MD
Perspectives on Treatment With OZURDEX (dexamethasone intravitreal implant) 0.7 mg
Sponsored by Allergan
Digital 3D Retina Surgery: Are We at the Precipice of a New Standard of Care?
Sponsored by Alcon
Treating Retinal Disorders: Updates for the Newer Retina Specialist
This CME activity is supported by an educational grant from Regeneron Pharmaceuticals, Inc.
Swept Source OCT & OCT Angiography
Sponsored by Topcon
Recent Supplements
Gaining Patients’ Buy-in With Geographic Atrophy Treatment: The Journey From Diagnosis to Long-term Adherence
Editorially Independent Content, Supported With Advertising From Astellas
View Insert
One to Watch: Hong-Uyen Hua, MD
Editorially independent supported by Abbvie and Regenxbio
Navigating Copays in Retina Care
View Supplement
Rising Stars in Retina: Fares Antaki, MDCM
Understanding Fast Progression in Geographic Atrophy
One to Watch: Jordan D. Deaner, MD
View More
Eyetube Retina Series
EYETUBE RETINA MEETING COVERAGE